COMMUNIQUÉS West-GlobeNewswire

Exalenz Bioscience’s Non-Invasive BreathID® Test to be Evaluated in Two Bristol-Myers Squibb Phase 2b Clinical Trials in Adult Patients with NASH
10/07/2018
Studies will use BreathID 13 C-methacetin breath test to evaluate patient response to therapy MODI’IN, Israel and MANASQUAN, N.J., July 10, 2018 (GLOBE NEWSWIRE) -- Exalenz Bioscience Ltd. (TASE:EXEN), a leader in [...]
Avalon GloboCare Appoints Senior Healthcare Executive William Stilley to Board of Directors
10/07/2018
FREEHOLD, N.J., July 10, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, today announced that it has appointed William B. Stilley to the Company’s [...]
VIVUS Announces Positive Results from a Phase 1 Clinical Trial of VI-0106
10/07/2018
-Favorable pharmacokinetic results add to body of data supporting continued development in the treatment of pulmonary arterial hypertension- CAMPBELL, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS [...]
International Stem Cell Corporation Expands Manufacturing Capabilities for Biomedical Products
10/07/2018
CARLSBAD, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- International Stem Cell Corporation (OTCQB:ISCO) ("ISCO" or "the Company"), a California-based clinical stage biotechnology company developing novel stem cell-based [...]
Summit Awarded up to $4.5 Million Grant from CARB-X for Development of New Mechanism Gonorrhoea Antibiotics
10/07/2018
Summit Therapeutics plc (‘Summit’ or the “’Company’) Summit Awarded up to $4.5 Million Grant from CARB-X for Development of New Mechanism Gonorrhoea Antibiotics Non-Dilutive Funding Could Support Development through [...]
Aptose Biosciences and CrystalGenomics Announce Issuance of Japanese Patent for CG-806
10/07/2018
SAN DIEGO, TORONTO, and SEOUL, July 10, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ:APTO) (TSX:APS), today announced that the Japan Patent Office has issued Japanese Patent No. [...]
Evogene Announces Positive Yield Results in its Bio-Stimulant Program for Wheat
10/07/2018
Product candidates have shown significant yield improvement in spring wheat field trials REHOVOT, Israel, July 10, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ:EVGN) (TASE:EVGN), a leading biotechnology company [...]
Kamada Receives Positive Scientific Advice from European Medicines Agency on a New Phase 3 Study Design for Inhaled AAT
10/07/2018
Company Plans to Submit Clinical Trial Application and Intends to Engage in Discussions for Strategic European Partner for Commercialization Rights for Inhaled AAT REHOVOT, Israel, July 10, 2018 (GLOBE NEWSWIRE) -- [...]
miRagen Therapeutics Announces Initiation of Phase 2 Clinical Trial of MRG-201
10/07/2018
BOULDER, Colo., July 10, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ:MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced [...]
Amydis Receives Parkinson’s Disease Grant from Michael J. Fox Foundation
10/07/2018
SAN DIEGO, July 10, 2018 (GLOBE NEWSWIRE) -- Amydis, Inc., a privately-held pharmaceutical company developing proprietary chemistry and innovative approaches for the detection of amyloid-related diseases, announced [...]
AxoGen, Inc. Appoints Lisa N. Colleran to Board of Directors
10/07/2018
Health care industry veteran brings 30+ years of executive experience to AxoGen, Inc. Board of Directors ALACHUA, Fla., July 10, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and [...]
Arbutus Presents Corporate Update on Key Milestones
10/07/2018
First Subject Dosed in Phase 1 Study of AB-506, Arbutus’ Second-Generation Capsid Inhibitor All-Oral Combination Study of AB-506 and AB-452 Expected in 2019 HBsAg Reduction Data from ARB-1467 Expected in Q4 Arbutus [...]
Ossur Hf : Q2 2018 Results - Conference call Thursday 26 July at 9:00 CET
10/07/2018
Announcement no. 44/2018 10 July 2018 Conference call on Thursday 26 July at 9:00 CET / 7:00 GMT / 3:00 EDT Össur will publish its financial results for Q2 2018 prior to market opening on Thursday 26 July. That same day [...]
ImmuCell Announces Preliminary Sales Results for Second Quarter of 2018
10/07/2018
PORTLAND, Maine, July 10, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq:ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Achillion Initiates Phase I First-in-Human Study of ACH-5548, a Third Oral Small Molecule Inhibitor of Complement Factor D
10/07/2018
- Additional clinical compounds expand factor D portfolio opportunities - NEW HAVEN, Conn., July 10, 2018 (GLOBE NEWSWIRE) -- Achillion Pharmaceuticals, Inc. (Nasdaq:ACHN), a clinical-stage pharmaceutical company [...]
Transactions in relation to share buyback program
10/07/2018
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
Helsinn: Glenmark Pharmaceuticals expands its oncology franchise in India with the launch of Helsinn’s AKYNZEO®, a combination drug for the prevention of chemotherapy-induced nausea and vomiting (CINV)
10/07/2018
Glenmark Pharmaceuticals expands its oncology franchise in India with the launch of Helsinn’s AKYNZEO ® , a combination drug for the prevention of chemotherapy-induced nausea and vomiting (CINV) AKYNZEO ® was developed [...]
SPINEWAY : Implementation of the new strategic plan Signature of a financing agreement
10/07/2018
Implementation of the new strategic plan Signature of a financing agreement with Alpha Blue Ocean for a reserved issue of OCEANE (bonds convertible into new or existing shares) with attached warrants As announced on 13 [...]
SPINEWAY : Mise en place du nouveau plan stratégique signature d'un contrat de financement
10/07/2018
Mise en place du nouveau plan stratégique Signature d'un contrat de financement avec Alpha Blue Ocean par émission réservée d'OCEANE assorties de BSA Conformément à l'annonce du 13 juin 2018, SPINEWAY, spécialiste des [...]

Pages